C. Jo White
Keine laufenden Positionen mehr
Profil
C.
Jo White worked as a Principal at Wyeth LLC, North American Vaccine, Inc., MedImmune Vaccines, Inc., and Merck, Inc. Additionally, White served as the Chief Medical Officer at Inovio Pharmaceuticals, Inc., VGX Pharmaceuticals LLC, and VaxInnate Corp.
White received an undergraduate degree from The University of Texas at Austin and a doctorate from Baylor College of Medicine.
Ehemalige bekannte Positionen von C. Jo White
| Unternehmen | Position | Ende |
|---|---|---|
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Corporate Officer/Principal | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
| Merck, Inc. | Corporate Officer/Principal | - |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | - |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von C. Jo White
| The University of Texas at Austin | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
VGX Pharmaceuticals LLC
 VGX Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGX Pharmaceuticals LLC develops pharmaceuticals. The company was founded by J. Joseph Kim and is headquartered in Blue Bell, PA. | Health Technology |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
| Merck, Inc. |
